Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine

JAMA Dermatol. 2019 Apr 1;155(4):491-493. doi: 10.1001/jamadermatol.2018.5212.

Authors

Kathryn Riley¹, Zachary Schwager¹, Marleigh Stern¹, Ruth Ann Vleugels², Alisa Femia¹

Affiliations

¹ Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Abstract

This study evaluates the use of antimalarial therapy in patients who are hydroxychloroquine hypersensitive.

Publication types

Multicenter Study

MeSH terms

Antimalarials / administration & dosage*
Antimalarials / adverse effects
Chloroquine / administration & dosage*
Chloroquine / adverse effects
Drug Eruptions / etiology*
Drug Eruptions / immunology
Humans
Hydroxychloroquine / administration & dosage*
Hydroxychloroquine / adverse effects
Retrospective Studies

Substances

Antimalarials
Hydroxychloroquine
Chloroquine